纽约 - Hoth Therapeutics, Inc. (NASDAQ:HOTH)今日宣布,中国国家知识产权局已授予其剪接转换寡核苷酸技术专利,该技术旨在诱导肥大细胞凋亡。 该专利名为"利用剪接转换寡核苷酸靶向Kit以诱导肥大细胞凋亡",最初以PCT申请号PCT/US2019/048400提交,由北卡罗来纳州立大学开发。根据新闻稿声明,该专利在中国的保护期至2039年8月27日,但需满足维护要求 ...
纽约 - Hoth Therapeutics, Inc. (NASDAQ:HOTH)今日发布新闻稿称,该公司公布了HT-001的药代动力学、安全性和临床活性数据。HT-001是一种外用治疗药物,目前正在接受EGFR疗法相关皮肤毒性的癌症患者中进行研究。这家处于临床阶段的生物制药公司市值为1450万美元,其股价在过去六个月下跌52%,目前交易价格为每股0.93美元。 药代动力学分析显示,平均AUC₀ ...
Unfortunately, we haven’t seen the smaller AT-AT bag pictured above, but odds are that it will be added soon. You can’t have a Hoth collection without a Tauntaun, and Bioworld delivered with this coin ...
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company focused on developing innovative therapies for unmet medical needs, today announced that the China National ...
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company, today announced the deployment of OpenClaw™, an advanced AI-enabled computational platform designed to accelerate ...
Not content to simply assemble an AT-AT figure and put it on his shelf like everyone else, this maker built an entire scale model of the Battle of Hoth. The Star Wars fan behind popular YouTube ...
(RTTNews) - Hoth Therapeutics (HOTH) announced its collaboration with OnTargetx R&D to advance research for its cancer-fighting therapeutic, HT-KIT. The study focuses on: development and optimization ...